MedTrace Logo

Effects of Vitamin D Supplementation During a Non-surgical Treatment of Generalized Chronic Periodontitis

NCT03162406 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-23

No results posted yet for this study

Summary

The subjects participating in the trial will be randomly allocated to either the group receiving the treatment under investigation (scaling and root planning (SRP) accompanied by administration of vitamin D) or to a group receiving standard treatment (SRP in conjunction with placebo) as the control. Random assignment of intervention will be done after subjects have been assessed for eligibility and recruited, but before the intervention to be studied begins. After randomization, the two groups of subjects will be followed in exactly the same way and the only differences between them will be the vitamin D/placebo that they will receive.

Conditions

  • Generalized Chronic Periodontitis
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Oral supplementation 25000 IU once per week for 6 months

DIETARY_SUPPLEMENT

Placebo

Oral supplementation once per week for 6 months

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Jérôme Lasserre, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

  • Etienne Cavalier, PhD · Professor and Head of the Department of Clinical Chemistry, CHU Sart-Tilman Liège

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-18
Primary Completion
2018-06-30
Completion
2018-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162406 on ClinicalTrials.gov